ArticleProceedings of the National Academy of Sciences of the United States of America2021

Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease.

Jodie Lord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.